VanVolkenburg M A, Griggs N D, Jarpe M A, Pace J L, Russell S W, Johnson H M
Department of Microbiology and Cell Science, University of Florida, Gainesville 32611.
J Immunol. 1993 Dec 1;151(11):6206-13.
We have studied the structural parameters involved in the binding of murine IFN-gamma (MuIFN-gamma) to its receptor. Ten synthetic overlapping peptides corresponding to the extracellular domain of the MuIFN-gamma receptor (MuIFN-gamma R) were synthesized. In direct binding studies, biotinylated MuIFN-gamma bound specifically to receptor peptide (95-120). Further, the NH2-terminal IFN-gamma peptide, MuIFN-gamma (1-39), also specifically bound to receptor peptide (95-120). Binding of both labeled MuIFN-gamma and MuIFN-gamma (1-39) to MuIFN-gamma R peptide (95-120) was inhibited by either unlabeled molecule. The COOH-terminal receptor binding peptide, MuIFN-gamma (95-133), neither bound to any receptor peptides nor blocked the binding of intact MuIFN-gamma or MuIFN-gamma (1-39) to receptor peptide (95-120). Polyclonal antibodies to each of the peptides were then produced. Each of the anti-peptide antisera recognized its corresponding peptide and bound denatured cloned soluble receptor by Western blotting. Furthermore, the antisera to peptides representing the inner region of the extracellular domain of the receptor bound to nondenatured soluble MuIFN-gamma R. Specifically, antisera to the receptor peptides (73-97), (95-120), (118-143), (142-163), and (161-182) bound to soluble MuIFN-gamma R, whereas antisera to peptides (1-21), (20-49), (46-74), (178-203), and (202-227) did not bind. Most important, antisera to peptides (95-120) and (118-143) competed with [125I]MuIFN-gamma for binding to soluble receptor. These results show that the region of the MuIFN-gamma R encompassing amino acid residues (95-120) is a binding site on the receptor for the NH2-terminal of MuIFN-gamma by direct binding, and that the larger region (95-143) on the receptor may play a role in binding of intact MuIFN-gamma based on blocking of binding by site-specific antibodies.
我们研究了参与小鼠γ干扰素(MuIFN-γ)与其受体结合的结构参数。合成了十条与MuIFN-γ受体(MuIFN-γR)胞外域对应的合成重叠肽。在直接结合研究中,生物素化的MuIFN-γ特异性结合受体肽(95 - 120)。此外,NH2端的IFN-γ肽,即MuIFN-γ(1 - 39),也特异性结合受体肽(95 - 120)。未标记的分子均可抑制标记的MuIFN-γ和MuIFN-γ(1 - 39)与MuIFN-γR肽(95 - 120)的结合。COOH端的受体结合肽,MuIFN-γ(95 - 133),既不与任何受体肽结合,也不阻断完整的MuIFN-γ或MuIFN-γ(1 - 39)与受体肽(95 - 120)的结合。随后制备了针对每种肽的多克隆抗体。每种抗肽抗血清都能识别其相应的肽,并通过蛋白质印迹法与变性的克隆可溶性受体结合。此外,针对代表受体胞外域内部区域的肽的抗血清能与非变性的可溶性MuIFN-γR结合。具体而言,针对受体肽(73 - 97)、(95 - 120)、(118 - 143)、(142 - 163)和(161 - 182)的抗血清能与可溶性MuIFN-γR结合,而针对肽(1 - 21)、(20 - 49)、(46 - 74)、(178 - 203)和(202 - 227)的抗血清则不结合。最重要的是,针对肽(95 - 120)和(118 - 143)的抗血清能与[125I]MuIFN-γ竞争结合可溶性受体。这些结果表明,MuIFN-γR中包含氨基酸残基(95 - 120)的区域是通过直接结合与MuIFN-γ的NH2端在受体上的结合位点,并且基于位点特异性抗体对结合的阻断,受体上更大的区域(95 - 143)可能在完整的MuIFN-γ结合中发挥作用。